Skip to main content
2024 DC-CSEM Conference Main banner
On-Demand

Accredited Symposium

AS2402 - Enhancing Uptake and Use of Glucose Sensing Technology

Thursday, November 21, 2024
12:45 - 13:45 AT Time
Location: Ballroom B3

    Presenter(s)

  • JK

    James W. Kim, MBBCh, PgDip, MScCH (he/him/his)

    Clinical Assistant Professor
    University of Calgary
    University of Calgary
    Calgary, Alberta, Canada

    Disclosure(s): Abbott Diabetes: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); Abbvie: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Speaker/Honoraria (Ongoing); Eisai: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly Canada: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); EMBECTA: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); GSK: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); Idorsia: Consultant (Ongoing); Lin Pharma: Advisory Board (Ongoing); MDBriefcase: Committee/Planning Member (Terminated); Novo Nordisk Canada: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); Otsuka: Consultant (Ongoing), Speaker/Honoraria (Ongoing); Pfizer: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Searchlight: Consultant (Ongoing), Speaker/Honoraria (Ongoing); Takeda Canada: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); Teva: Speaker/Honoraria (Ongoing)

  • ER

    Elizabeth Rosolowsky, MD, MPH (she/her/hers)

    Divisional Director, Pediatric Endocrinology & Metabolism Associate Professor of Pediatrics
    University of Alberta
    University of Alberta
    Edmonton, Alberta, Canada

    Disclosure information not submitted.

  • Michelle Stewart, RPh (she/her/hers)

    CDE
    The Pangaea Group
    Westville, Nova Scotia, Canada

    Disclosure(s): Abbott Canada: Speaker/Honoraria (Ongoing); GSK: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordik: Speaker/Honoraria (Ongoing)

    • Moderator(s)

  • JY

    Jean-Francois Yale, MD (he/him/his)

    Professor of endocrinology
    McGill University
    McGill University
    Mirabel, Quebec, Canada

    Disclosure(s): Abbott Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Bayer Canada: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Dexcom Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly & Company: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordisk Canada: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Sanofi: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing)

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada and approved by the Canadian Society of Endocrinology and Metabolism.
This accredited symposium was co-developed with the Canadian Society of Endocrinology and Metabolism and Abbott and was planned to achieve scientific integrity, objectivity and balance.

Learning Objectives:

  • Analyze the various sociodemographic and psychosocial factors influencing the uptake and continued use of glucose sensing technology in patients with type 1 and type 2 diabetes.
  • Evaluate the current landscape of access to glucose sensing technology across Canada, including provincial differences and private insurance coverage.
  • Formulate strategies to overcome barriers and optimize early access to glucose sensing technology within various Canadian sociodemographic contexts.